GSK-3 inhibitor LY2090314, Purity ≥98%

Synonym: 603288-22-8; LY 2090314; LY-2090314; GSK-3 inhibitor

CAS Number: 603288-22-8
Compound CID: 10029385

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

LY2090314, soluble in DMSO and warmed ethanol and insoluble in water, modulates various cellular processes, including glucose metabolism, inflammation, and cell proliferation, with potential applications in treating diseases like diabetes and neurodegenerative disorders. It targets GSK-3α and GSK-3β.

Molecular Weight

512.53

Molecular Formula

C₂₈H₂₅FN₆O₃

Targets

GSK-3α: 1.5 nM; GSK-3β: 0.9 nM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 93 mg/mL (181.45 mM); Water: Insoluble; Warmed ethanol: 2 mg/mL (3.9 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

LY2090314 can be used to inhibit GSK-3 in studies focusing on oncology and regenerative medicine.